Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,385,208 papers from all fields of science
Search
Sign In
Create Free Account
Pyranocoumarins
Known as:
Pyranocoumarins [Chemical/Ingredient]
A type of COUMARINS with added pyran ring(s).
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Narrower (6)
Calanolides
calanolide A
calanolide B
calanolide C
Expand
In Blood
agonists
antagonists & inhibitors
aspects of radiation effects
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats.
Elix Alberto Domínguez-Mendoza
,
J. Cornejo-Garrido
,
E. Burgueño-Tapia
,
C. Ordaz-Pichardo
Bioorganic & Medicinal Chemistry Letters
2016
Corpus ID: 32971175
2016
2016
Effective and novel enantioselective preparation of pyranopyrazoles and pyranocoumarins that is catalyzed by a quinine-derived primary amine.
Sai-Zhen Yang
,
L. Shen
,
Yoon-Jung Kim
,
Jin-Hyun Jeong
Organic and biomolecular chemistry
2016
Corpus ID: 11297395
In this study, we executed an effective and novel enantioselective Michael/cyclodehydration sequential reaction between pyrazolin…
Expand
2015
2015
Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis
Suni Tang
,
Jinhui Zhang
,
+7 authors
J. Lü
Cancer Prevention Research
2015
Corpus ID: 13238496
We showed previously that daily gavage of Angelica gigas Nakai (AGN) root ethanolic extract starting 8 weeks of age inhibited…
Expand
2013
2013
Praeruptorin D and E attenuate lipopolysaccharide/hydrochloric acid induced acute lung injury in mice.
Peng-Jiu Yu
,
Jing-rong Li
,
+8 authors
Shu‐guang Wu
European Journal of Pharmacology
2013
Corpus ID: 24303683
Highly Cited
2009
Highly Cited
2009
Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
Chung-Ren Su
,
S. Yeh
,
+6 authors
Tian-Shung Wu
Bioorganic & Medicinal Chemistry
2009
Corpus ID: 28801466
2009
2009
New tricyclic and tetracyclic pyranocoumarins with an unprecedented C‐4 substituent. Structure elucidation of tamanolide, tamanolide D and tamanolide P from Calophyllum inophyllum of French Polynesia
T. Leu
,
P. Raharivelomanana
,
S. Soulet
,
J. Bianchini
,
G. Herbette
,
R. Faure
Magnetic resonance in chemistry : MRC
2009
Corpus ID: 24274651
Three new pyranocoumarin derivatives, tamanolide (1), tamanolide D (2) and tamanolide P (3), were isolated from the almond seeds…
Expand
Highly Cited
2008
Highly Cited
2008
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
W. Fong
,
Xiao-Ling Shen
,
+6 authors
Ying-Jie Hu
Bioorganic & Medicinal Chemistry
2008
Corpus ID: 5217022
2004
2004
Two pyranocoumarins from the seeds of Calophyllum polyanthum.
Chun-hui Ma
,
Bin Chen
,
Huayi Qi
,
Bo-gang Li
,
Guo-lin Zhang
Journal of Natural Products
2004
Corpus ID: 30898473
Two new pyranocoumarin diastereoisomers, calopolyanolides C (1) and D (2), were isolated from the ethanolic extract of the seeds…
Expand
1986
1986
Effects of modifier and molecular structure of some coumarins on retention in reversed-phase high-performance thin-layer and column chromatography.
K. Głowniak
,
M. Bieganowska
Journal of Chromatography A
1986
Corpus ID: 20640599
1986
1986
Photobiological activity of certain pyranocoumarin derivatives: potential agents for the photochemotherapy of psoriasis.
F. Baccichetti
,
P. Rodighiero
,
+5 authors
F. Bordin
Photo-dermatology
1986
Corpus ID: 20263097
The photobiological properties of a series of pyranocoumarin derivatives having linear (xanthyletines) and angular structure…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE